Current Areas of Focus

At Santen, we’re dedicated to developing new solutions that address the mounting ophthalmology challenges eye care professionals face today. Our focus is on developing and bringing a broad array of differentiated solutions to market, which range from innovative eye disease treatments to novel diagnostics, devices, delivery systems, and more.

Putting Patients First

At the heart of this effort is our commitment to fueling hope and improving quality of life for patients and their families dealing with vision impairment or vision loss.

Seeing Future Possibilities

Santen is actively researching and developing new solutions for unmet medical needs in these categories:

Retinal Diseases
Close up of retina. Santen is dedicated to developing opthalmalmology treatments and medications for  retinal diseases.
  • Intraocular inflammation (Uveitis)
  • Age-related degenerative eye diseases
Glaucoma
Close up of glaucoma in eye. Santen develops opthalmalmology treatments and medications for glaucoma.
  • Ocular hypertension
  • Neuroprotection
Dry Eye & Corneal Disorders
Close up of cornea. Santen develops opthalmalmology treatments and medications for dry eye and corneal disorders.
  • Dry eye and meibomian gland disease
  • Corneal and conjunctival epithelial disorders
Refractive Disorders
Close up of eye. Santen develops opthalmalmology treatments and medications for refractive disorders.
  • Myopia
  • Presbyopia
At Santen, we believe cutting-edge science can make a meaningful difference when it comes to preserving vision.
Naveed Shams, MD, PhD
Chief Scientific Officer, Head of Global R&D

SEE WHAT’S IN
OUR PIPELINE

Get Details

PARTNER
WITH US

Learn More